お知らせ

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.

業績番号:2016-3

S.Sugai, T.Yoshikawa, T.Iwama, N.Tsuchiya, N.Ueda, N.Fujinami, M.Shimomura, R.Zhang, S.Kaneko, Y.Uemura and T.Nakatsura.

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.

Methods in Molecular Biology 01 April 2016.

26936487

https://doi.org/10.3892/ijo.2016.3403